Title 42 — The Public Health and WelfareRelease 119-73
§300b–1 Research project grants and contracts
Title 42 › Chapter CHAPTER 6A— - PUBLIC HEALTH SERVICE › Subchapter SUBCHAPTER IX— - GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME › Part Part A— - Genetic Diseases › § 300b–1
Summary
The Secretary can give grants to public and nonprofit groups and make contracts with public or private groups and people to support work on genetic diseases. Projects can be research, training programs for genetic counselors and other health workers, education for doctors and the public about genetics and how to diagnose and treat these diseases, and counseling and testing programs. For research, the Secretary must give priority to sickle cell anemia and Cooley’s anemia.
Full Legal Text
Title 42, §300b–1
The Public Health and Welfare — Source: USLM XML via OLRC
In carrying out section 241 of this title, the Secretary may make grants to public and nonprofit private entities, and may enter into contracts with public and private entities and individuals, for projects for (1) basic or applied research leading to the understanding, diagnosis, treatment, and control of genetic diseases, (2) planning, establishing, demonstrating, and developing special programs for the training of genetic counselors, social and behavioral scientists, and other health professionals, (3) the development of programs to educate practicing physicians, other health professionals, and the public regarding the nature of genetic processes, the inheritance patterns of genetic diseases, and the means, methods, and facilities available to diagnose, control, counsel, and treat genetic diseases, and (4) the development of counseling and testing programs and other programs for the diagnosis, control, and treatment of genetic diseases. In making grants and entering into contracts for projects described in clause (1) of the preceding sentence, the Secretary shall give priority to applications for such grants or contracts which are submitted for research on sickle cell anemia and for research on Cooley’s anemia.
Legislative History
Notes & Related Subsidiaries
Editorial Notes
Prior Provisions
A prior section 300b–1, act
July 1, 1944, ch. 373, title XI, § 1102, as added
May 16, 1972, Pub. L. 92–294, § 3(c), 86 Stat. 138, authorized Secretary to make grants and enter contracts with public and private entities and individuals for projects concerned with research, research training in diagnosis, treatment and control of sickle cell anemia, informational and educational programs with respect to sickle cell anemia and development of counseling and testing programs, prior to repeal by Pub. L. 94–278, title IV, § 403(a), Apr. 22, 1976, 90 Stat. 407.
Statutory Notes and Related Subsidiaries
Effective Date
Pub. L. 94–278, title IV, § 403(c), Apr. 22, 1976, 90 Stat. 410, provided that: “The
Amendments
made by subsections (a) and (b) [see section 401 of Pub. L. 94–278, set out as a
Short Title
of 1976 Amendment note under section 201 of this title] shall take effect July 1, 1976.”
Short Title
of 1976 AmendmentFor
Short Title
of title IV of Pub. L. 94–278, which enacted this part, omitted former part B of this subchapter, redesignated former parts C and D of this subchapter as parts B and C of this subchapter, respectively, as the “National Sickle Cell Anemia, Cooley’s Anemia, Tay-Sachs, and Genetic Diseases Act”, see section 401 of Pub. L. 94–278, set out as a note under section 201 of this title. Demonstration Program for the Development and Establishment of Systemic Mechanisms for the Prevention and Treatment of Sickle Cell Disease Pub. L. 108–357, title VII, § 712(c), Oct. 22, 2004, 118 Stat. 1559, as amended by Pub. L. 115–327, § 3(a), Dec. 18, 2018, 132 Stat. 4469, which was formerly set out as a note under this section, was transferred to section 300b–5(b) of this title by Pub. L. 115–327, § 3(b), Dec. 18, 2018, 132 Stat. 4470. Congressional Declaration of Purpose Pub. L. 94–278, title IV, § 402, Apr. 22, 1976, 90 Stat. 407, as amended by Pub. L. 95–626, title II, § 205(a), Nov. 10, 1978, 92 Stat. 3583; Pub. L. 111–256, § 2(i), Oct. 5, 2010, 124 Stat. 2644, provided that: “In order to preserve and protect the health and welfare of all citizens, it is the purpose of this title [see section 401 of Pub. L. 94–278, set out as a
Short Title
of 1976 Amendment note under section 201 of this title] to establish a national program to provide for basic and applied research, research training, testing, counseling, and information and education programs with respect to genetic diseases, and genetic conditions, such as Sickle Cell anemia, Cooley’s Anemia, Tay–Sachs disease, cystic fibrosis, dysautonomia, hemophilia, retinitis pigmentosa, Huntington’s chorea, muscular dystrophy, and genetic conditions leading to intellectual disabilities or genetically caused mental disorders.” [For meaning of references to an intellectual disability and to individuals with intellectual disabilities in provisions amended by section 2 of Pub. L. 111–256, see section 2(k) of Pub. L. 111–256, set out as a note under section 1400 of Title 20, Education.]
Reference
Citations & Metadata
Citation
42 U.S.C. § 300b–1
Title 42 — The Public Health and Welfare
Last Updated
Apr 6, 2026
Release point: 119-73